Skip to main content
SpringerLink
Log in

Botulinum Toxin for Hyperhidrosis in the Axillary Area

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Botulinum Toxins, Fillers and Related Substances

  • 234 Accesses

Abstract

Axillary hyperhidrosis (AH) impacts social and occupational lives of lots of people in all continents, and its real incidence probably is underestimated. Botulinum toxin is a safe and effective treatment option for axillary hyperhidrosis. Although its pathophysiology is not very clear, with some controversial topics, so far the beneficial effect of neuromodulators in inhibiting localized sweating temporarily is well known.

Before the procedure, the correct identification of the affected area is mandatory. The objective is to enhance efficacy avoiding drug waste or leaving areas without treatment, because the hyperhidrotic location does not always match the hairy axillary region.

Handling this medication, including dilution and injection techniques, depends on medical experience and may have some variations, including methods to make the procedure as painless as possible. Evidence supports a Level A recommendation for BoNT-A for axillary hyperhidrosis.

Conflict of Interest

Dr. Ada has been a consultant in Allergan, Inc. and participated in clinical trials for Allergan and Galderma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • An JS, Hyun Won C, Si Han J, Park HS, Seo KK. Comparison of onabotulinumtoxinA and rimabotulinumtoxinB for the treatment of axillary hyperhidrosis. Dermatol Surg. 2015;41(8):960–7.

    Article  CAS  PubMed  Google Scholar 

  • Atkins JL, Butler PEM. Hyperhidrosis: a review of current management. Plast Reconstr Surg. 2002;110:222–8.

    Article  PubMed  Google Scholar 

  • Bahmer F, Sachse M. Hyperhidrosis area and severity index (letter). Dermatol Surg. 2008;34:1744–5.

    CAS  PubMed  Google Scholar 

  • Baumann L, et al. Pilot study of the safety and efficacy of MyoblocTM (botulinum toxin type B) for treatment of axillary hyperhidrosis. Int J Dermatol. 2005;44:418–24.

    Article  CAS  PubMed  Google Scholar 

  • Bechara F. Do we have apocrine sweat glands? Int J Cosmet Sci. 2008;30:67–8.

    Article  CAS  PubMed  Google Scholar 

  • Bovell DL, Clunes MT, Elder HY, Milsom J, Mc Ewan Jenkinson D. Ultrastructure of the hyperhidrotic eccrine sweat gland. Br J Dermatol. 2001;145:298–301.

    Article  CAS  PubMed  Google Scholar 

  • Bovell D, Corbett A, Holmes S, et al. The absence of apocrine glands in the human axilla has disease pathogenetic implications, including axillary hyperhidrosis. Br J Dermatol. 2007;156:1278–86.

    Article  CAS  PubMed  Google Scholar 

  • Bovell DL, et al. The secretory clear cell of the eccrine sweat gland as the probable source of excess sweat production in hyperhidrosis. Exp Dermatol. 2011;20(12):1017–20.

    Article  CAS  PubMed  Google Scholar 

  • Brehmer F, Lockmann A, Grönemeyer LL, Kretschmer L, Schön MP, Thoms KM. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients. J Dtsch Dermatol Ges. 2015;13(8):799–805.

    PubMed  Google Scholar 

  • Burks RI. Povidone-iodine solution in wound treatment. Phys Ther. 1998;78(2):212–8.

    Article  CAS  PubMed  Google Scholar 

  • Bushara KO, Park DM. Botulinum toxin and sweating (Letter). J Neurol Neurosurg Psychiatry. 1994;54(11):1437.

    Article  Google Scholar 

  • Carruthers A, Alastair J. You want to inject what? Dermatol Surg. 2015;41:S2–8.

    Article  CAS  PubMed  Google Scholar 

  • Chow A, Wilder-Smith EP. Effect of transdermal botulinum toxin on sweat secretion in subjects with idiopathic palmar hyperhidrosis. Br J Dermatol. 2009;160(3):721–3.

    Article  CAS  PubMed  Google Scholar 

  • Cohen JL, Cohen G, Solish N, et al. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy. Facial Plast Surg Clin North Am. 2007;15:17–30, v–vi.

    Article  PubMed  Google Scholar 

  • De Campos JR, Kauffman P, Werebe Ede C, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76:886–91.

    Article  PubMed  Google Scholar 

  • Doft MA, Kasten JL, Ascherman JA. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon’s experience with 53 consecutive patients. Aesthet Plast Surg. 2011;35:1079–86.

    Article  Google Scholar 

  • Dressler D. Comparing Botox and Xeomin for axillar hyperhidrosis. J Neural Transm. 2010;117:317–9.

    Article  PubMed  Google Scholar 

  • Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol. 2002;249(12):1729–32.

    Article  CAS  PubMed  Google Scholar 

  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

    Article  CAS  PubMed  Google Scholar 

  • Frasson E, Brigo F, Acler M, Didine G, Vicentini S, Bertolase L. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Arch Dermatol. 2011;147(1):122–3.

    Article  PubMed  Google Scholar 

  • Glaser DA, Hebert AA, Pariser DM, Solish N. Primary focal hyperhidrosis: scope of the problem. Cutis. 2007;79(5):5–17.

    PubMed  Google Scholar 

  • Glogau R. Hyperhidrosis and botulinum toxin A: patient selection and techniques. Clin Dermatol. 2004;22:45–52.

    Article  PubMed  Google Scholar 

  • Glogau RG. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg. 2007;33(1):S76–80.

    Article  CAS  PubMed  Google Scholar 

  • Glogau R, Blitzer A, Brandt F, Kane M, Monheit GD, Waugh JM. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines. J Drugs Dermatol. 2012;11(1):38–45.

    Google Scholar 

  • Goodman G. Diffusion and short-term efficacy of botulinum toxin A after addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg. 2003;29:533–8.

    PubMed  Google Scholar 

  • Grimalt R, Moreno-Arias GA, Ferrando J. Multi-Injection plate for botulinum toxin application in the treatment of axillary hyperhidrosis. Dermatol Surg. 2001;27:543–4.

    CAS  PubMed  Google Scholar 

  • Grunfeld A, Murray CA, Solish N. Botulinum toxin for hyperhidrosis: a review. Am J Clin Dermatol. 2009;10(2):87–102.

    Article  PubMed  Google Scholar 

  • Gülec AT. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study. J Eur Acad Dermatol Venereol. 2012;26:314–8.

    Article  PubMed  Google Scholar 

  • Hamm H, Naumann MK, Kowalski JW, Kutt S, Kozma C, Teale C. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology. 2006;212:343–53.

    Article  PubMed  Google Scholar 

  • Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344(7):488–93.

    Article  CAS  PubMed  Google Scholar 

  • Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LR. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51:274–86.

    Article  PubMed  Google Scholar 

  • Hund M, Kinkelin I, Naumann M, et al. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol. 2002;138:539–41.

    Article  PubMed  Google Scholar 

  • Jain S. A new multiple site marking grid for botulinum toxin application in the treatment of axillary hyperhidrosis. Br J Dermatol. 2006;154:375–91.

    Article  Google Scholar 

  • Kalner IJ. Same-patient prospective comparison of Botox versus Dysport for treatment of primary axillary hyperhidrosis and review of literature. J Drugs Dermatol. 2011;10(9):1013–5.

    Google Scholar 

  • Klein AW. Complication, adverse reaction, and insights with the use of botulinum toxin. Dermatol Surg. 2003;29:549–56.

    PubMed  Google Scholar 

  • Kreyden O, Scheidegger E. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol. 2004;22:40–4.

    Article  PubMed  Google Scholar 

  • Lakraj AAD, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins. 2013;5:821–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lecouflet M, Leux C, Fenot M, Celerier P, Maillard H. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients. J Am Acad Dermatol. 2013;69(6):960–4.

    Article  CAS  PubMed  Google Scholar 

  • Lindsay SL, Holmes S, Corbett AD, Harker M, Bovell DL. Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol. 2008;159:653–60.

    Article  CAS  PubMed  Google Scholar 

  • Lowe NJ, Glaser DA, Eadie N, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of eficacy and safety. J Am Acad Dermatol. 2007;56(4):604–11.

    Article  PubMed  Google Scholar 

  • Mota JJ, Sotto MN. Anatomy and histology of sweat glands. In: Almeida ART, Hexsel DM. editors. Hyperhidrosis and botulinum toxin, vol. 1. Edition of authors. São Paulo; 2004. p. 3–6.

    Google Scholar 

  • Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. Br Med J. 2001;323(7):596–9.

    Article  CAS  Google Scholar 

  • Naumann M, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013;67:141–52.

    Article  CAS  PubMed  Google Scholar 

  • Nelson L, Bachoo P, Holmes J. Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg. 2005;58:228–32.

    Article  CAS  PubMed  Google Scholar 

  • Odderson IR. Long-term quantitative benefits of botulinum toxin A in the treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28:480–3.

    PubMed  Google Scholar 

  • Rosell K, Hymnelius K, Swartling C. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol. 2013;93:335–9.

    Article  PubMed  Google Scholar 

  • Sato K, Kang WH, Saga KT. Biology of sweat glands and their disorders I. Normal sweat gland function. J Am Acad Dermatol. 1989a;20:537–63.

    Article  CAS  PubMed  Google Scholar 

  • Sato K, Kang WT, Saga KT. Biology of sweat glands and their disorders II. Disorders of sweat gland function. J Am Acad Dermatol. 1989b;20:713–26.

    Article  CAS  PubMed  Google Scholar 

  • Scamoni S, Valdatta L, Frigo C, Maggiulli F, Cherubino M. Treatment of primary axillary hyperhidrosis with botulinum toxin type A: our experience in 50 patients from 2007 to 2010. ISRN Dermatol. 2012;2012:1–5.

    Article  Google Scholar 

  • Singh S, Davis H, Wilson P. Axillary hyperhidrosis: a review of the extent of the problem and treatment modalities. Surgeon. 2015;13(5):279–85.

    Article  PubMed  Google Scholar 

  • Skiveren J, Larsen HN, Kjaerby E, Larsen R. The influence of needle size on pain perception in patients treated with botulinum toxin A injections for axillary hyperhidrosis. Acta Derm Venereol. 2011;91:72–4.

    Article  CAS  PubMed  Google Scholar 

  • Strutton DR, Kowalski JW, Glaser DA, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241–8.

    Article  PubMed  Google Scholar 

  • Talarico-Filho S, Mendonça DO, Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg. 2007;33(1):44–50.

    Article  Google Scholar 

  • Trindade De Almeida AR, Secco LC, Carruthers A. Handling botulinum toxins: an updated literature review. Dermatol Surg. 2011;37(11):1553–65.

    Article  CAS  PubMed  Google Scholar 

  • Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol. 2007;156:986–9.

    Article  CAS  PubMed  Google Scholar 

  • Wolosker N, Munia MA, Kauffman P, et al. Is gender a predictive for satisfaction among patients undergoing sympathectomy to treat palmar hyperhidrosis? Clinics. 2010;65:583–6.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Hospital do Servidor Público Municipal de São Paulo (SP), São Paulo, São Paulo, Brazil

    Ada Regina Trindade de Almeida

  2. University of São Paulo, Campinas, São Paulo, Brazil

    Suelen Montagner

Authors
  1. Ada Regina Trindade de Almeida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suelen Montagner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ada Regina Trindade de Almeida .

Editor information

Editors and Affiliations

  1. Universidade Federal Fluminense, Niterói, São Paulo, Brazil

    Maria Claudia Almeida Issa

  2. Lexbios Medica S/S, São Paulo, São Paulo, Brazil

    Bhertha Tamura

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Trindade de Almeida, A.R., Montagner, S. (2019). Botulinum Toxin for Hyperhidrosis in the Axillary Area. In: Issa, M., Tamura, B. (eds) Botulinum Toxins, Fillers and Related Substances. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20253-2_9-3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20253-2_9-3

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-20253-2

  • Online ISBN: 978-3-319-20253-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Botulinum Toxin for Hyperhidrosis in the Axillary Area
    Published:
    03 January 2019

    DOI: https://doi.org/10.1007/978-3-319-20253-2_9-3

  2. Botulinum Toxin for Hyperhidrosis in the Axillary Area
    Published:
    17 May 2017

    DOI: https://doi.org/10.1007/978-3-319-20253-2_9-2

  3. Original

    Toxins for Hyperhidrosis in the Axillary Area
    Published:
    21 November 2016

    DOI: https://doi.org/10.1007/978-3-319-20253-2_9-1

Search

Navigation